Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "D11A" (189)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Antihidrotics (D11AA) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Antihydral
25 g
k.A.
Ointment: Methenaminum 130 mg
steinberg pharma ag
D / LPPV
FB
G
IP
CI
Sansudor
60 ml
5.92
10.90
k.A.
Cream: Dialuminii Chloridum Pentahydroxidum 190 mg
Boehringer Ingelheim
(Schweiz) GmbH
D
FB
G
Agents for Dermatitis, Excluding Corticosteroids (D11AH) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Alitretinoin Leman 10 mg
30
165.00
199.65
10 %
Soft capsules: Alitretinoinum 10 mg
Leman SKL SA
A / SL / SG
FB
G
L
IP
CI
Alitretinoin Leman 30 mg
30
165.00
199.65
10 %
Soft capsules: Alitretinoinum 30 mg
Leman SKL SA
A / SL / SG
FB
G
Alitretinoin (D11AH04) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Toctino 10 mg
30 Capsule(s)
181.45
216.50
10 %
Soft capsules: Alitretinoinum 10 mg
GlaxoSmithKline AG
A / SL / SO
FB
G
L
IP
CI
Toctino 30 mg
30 Capsule(s)
181.45
216.50
10 %
Soft capsules: Alitretinoinum 30 mg
GlaxoSmithKline AG
A / SL / SO
FB
G
L
IP
CI
Alitrecutan 10 mg
30
181.49
216.55
10 %
Soft capsules: Alitretinoinum 10 mg
Dermapharm AG
A / SL / SG
FB
G
L
IP
CI
Alitrecutan 30 mg
30
181.49
216.55
10 %
Soft capsules: Alitretinoinum 30 mg
Dermapharm AG
A / SL / SG
FB
G
Dupilumab (D11AH05) 6 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Dupixent 300 mg/2 ml
2
1019.78
1125.50
10 %
solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 300mg / 2ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
Dupixent 200 mg/1.14 ml
2
1019.78
1125.50
10 %
solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 200mg / 1.14ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
Dupixent 300 mg/ 2 ml
2 x 2 ml
1019.78
1125.50
10 %
solution injectable en stylo pré-rempli: Dupilumabum 300mg / 2ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
Dupixent 200 mg/ 1.14 ml
2 x 1.14 ml
1019.78
1125.50
10 %
solution injectable en stylo pré-rempli: Dupilumabum 200mg / 1.14ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Dupixent 300 mg/ 2 ml
2 x 2 ml
1065.68
1175.40
k.A.
solution injectable en stylo pré-rempli: Dupilumabum 300mg / 2ml
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
Dupixent 200 mg/ 1.14 ml
2 x 1.14 ml
1065.68
1175.40
k.A.
solution injectable en stylo pré-rempli: Dupilumabum 200mg / 1.14ml
Sanofi-Aventis
(Suisse) SA
B
FB
G
Abrocitinib (D11AH08) 6 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Cibinqo 50 mg
28
853.98
945.15
10 %
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B / SL
FB
G
L
IP
CI
Cibinqo 100 mg
28
853.98
945.15
10 %
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B / SL
FB
G
IP
CI
Cibinqo 50 mg
14
k.A.
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B
FB
G
IP
CI
Cibinqo 50 mg
91
k.A.
Coated tablets: Abrocitinibum 50 mg
Pfizer AG
B
FB
G
IP
CI
Cibinqo 100 mg
14
k.A.
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B
FB
G
IP
CI
Cibinqo 100 mg
91
k.A.
Coated tablets: Abrocitinibum 100 mg
Pfizer AG
B
FB
G
Other Dermatologicals (D11AX) 39 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Ph
Kamillex
100 ml
3.60
6.65
10 %
Streuli Pharma AG
D / SL
FB
G
IP
CI
Ph
Kamillex
200 ml
6.35
11.75
10 %
Streuli Pharma AG
D / SL
FB
G
L
CI
Linola
40 g
3.40
6.30
10 %
Emulsion: Acida Oligoinsaturata 5 mg/g
Alcina AG
D / SL
FB
G
L
CI
Linola
100 g
7.02
12.95
10 %
Emulsion: Acida Oligoinsaturata 5 mg/g
Alcina AG
D / SL
FB
G
L
CI
Linola Fett
40 g
3.40
6.30
10 %
Emulsion: Acida Oligoinsaturata 8.15 mg/g
Alcina AG
D / SL
FB
G
L
CI
Linola Fett
100 g
7.02
12.95
10 %
Emulsion: Acida Oligoinsaturata 8.15 mg/g
Alcina AG
D / SL
FB
G
IP
CI
Actikerall
25 ml
34.81
54.25
10 %
Solution: 2 Active Agents
Almirall AG
A / SL
FB
G
IP
CI
Ph
Kamillex
500 ml
19.30
k.A.
Streuli Pharma AG
● 
D
FB
G
CI
Ph
Phytovir Creme
5 g
k.A.
Cream: 2 Active Agents
ebi-pharm ag
D
FB
G
CI
Linola
50 g
k.A.
Emulsion: Acida Oligoinsaturata 5 mg/g
Alcina AG
D
FB
G
CI
Linola Fett
50 g
k.A.
Emulsion: Acida Oligoinsaturata 8.15 mg/g
Alcina AG
D
FB
G
IP
CI
Perskindol Cool
100 ml
k.A.
Gel: Levomentholum 70 mg
VERFORA SA
E
FB
G
CI
Pantogar
90 Capsule(s)
56.85
k.A.
Capsules: 6 Active Agents
Merz Pharma (Schweiz) AG
D / LPPV
FB
G
CI
Pantogar
300 Capsule(s)
146.65
k.A.
Capsules: 6 Active Agents
Merz Pharma (Schweiz) AG
D / LPPV
FB
G
CI
Priorin N
90 Capsule(s)
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D / LPPV
FB
G
CI
Priorin N
270 Capsule(s)
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D / LPPV
FB
G
IP
CI
Tannosynt flüssig
100 g
4.44
8.20
k.A.
Konzentrat zur Herstellung einer Lösung zur Anwendung auf der Haut: Phenoli/phenoli Sulfonatis/formaldehydi/urei Condensatum Natricum 400 mg/g
Almirall AG
D
FB
G
IP
CI
Perskindol Cool Spray
250 ml
k.A.
solution pour pulvérisation cutanée: Levomentholum 5 mg/g
VERFORA SA
E
FB
G
CI
Linola
150 g
k.A.
Emulsion: Acida Oligoinsaturata 5 mg/g
Alcina AG
D
FB
G
CI
Linola Fett
150 g
k.A.
Emulsion: Acida Oligoinsaturata 8.15 mg/g
Alcina AG
D
FB
G
CI
Priorin N
90 Capsule(s)
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D
FB
G
CI
Priorin N
180 Capsule(s)
97.30
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D
FB
G
CI
Priorin N
180 Capsule(s)
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D / LPPV
FB
G
CI
Priorin N
270 Capsule(s)
k.A.
Capsules: 4 Active Agents
Bayer (Schweiz) AG
D
FB
G
Moorschwebstoffbad
Schwanberg
7 Portionenbeutel à 250 g
k.A.
Bath essence: Terra Uliginosa "schwanberg"
Kurz Hermann
D
FB
G
IP
Medizinisches Badesalz aus dem
Toten Meer
1.5 kg
k.A.
Bath salt: 8 Active Agents
Parsenn-Produkte AG
D
FB
G
IP
Medizinisches Badesalz aus dem
Toten Meer
3 x 1.5 kg
k.A.
Bath salt: 8 Active Agents
Parsenn-Produkte AG
D
FB
G
IP
Medizinisches Badesalz aus dem
Toten Meer
10 kg
k.A.
Bath salt: 8 Active Agents
Parsenn-Produkte AG
D
FB
G
Phlogidermil
50 g
k.A.
Ointment: 6 Active Agents
Corden Pharma
Fribourg SA
D
FB
G
Phlogidermil
90 g
k.A.
Ointment: 6 Active Agents
Corden Pharma
Fribourg SA
D
FB
G
CI
Topaceta
50 g
k.A.
Ointment: 3 Active Agents
G. Streuli & Co. AG
D
FB
G
CI
Topaceta
100 g
k.A.
Ointment: 3 Active Agents
G. Streuli & Co. AG
D
FB
G
Tannolact Lotio
75 g
k.A.
Galderma SA
C
FB
G
IP
CI
Tannosynt
100 g
k.A.
Lotion: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
C
FB
G
Homosan
180 Dragée(s)
k.A.
Dragées: Keratinum Hydrolysatum 250 mg
Sanfarm SA
D
FB
G
IP
CI
Gelacet
189 Capsule(s)
k.A.
Capsules: 3 Active Agents
Reckitt Benckiser
(Switzerland) AG
D
FB
G
Mavala
5 ml
k.A.
Solution: 3 Active Agents
Mavala SA
E
FB
G
Trind Nail-Repair
brillant
11 ml
k.A.
Solution: 2 Active Agents
PHP Distribution
Sélective SA
E
FB
G
Trind Nail-Repair mat
11 ml
k.A.
Solution: 2 Active Agents
PHP Distribution
Sélective SA
E
FB
G
Minoxidil (D11AX01) 22 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Alopexy 2%
60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
Pierre Fabre Pharma SA
D / LPPV
FB
G
IP
CI
Alopexy 2%
3 x 60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
Pierre Fabre Pharma SA
D / LPPV
FB
G
IP
CI
Regaine 2 %
60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 2 %
3 x 60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 5 %
60 ml
k.A.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Regaine 5 %
3 x 60 ml
k.A.
Solution: Minoxidilum 50 mg/ml
JNTL Consumer Health II
(Switzerland) GmbH
D / LPPV
FB
G
IP
CI
Alopexy 5%
60 ml
k.A.
Lösung zur Anwendung auf der Haut: Minoxidilum
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Alopexy 5%
3 x 60 ml
k.A.
Lösung zur Anwendung auf der Haut: Minoxidilum
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Regaine 5%
3 x 60 g
k.A.
Schaum zur Anwendung auf der Haut: Minoxidilum 50 mg/g
JNTL Consumer Health II
(Switzerland) GmbH
D
FB
G
IP
CI
Minorga 5%
60 ml
k.A.
solution pour aplication cutanée: Minoxidilum 50 mg/ml
Bailleul (Suisse) SA
D
FB
G
IP
CI
Minorga 5%
3 x 60 ml
k.A.
solution pour aplication cutanée: Minoxidilum 50 mg/ml
Bailleul (Suisse) SA
D
FB
G
IP
CI
Minorga 2 %
60 ml
k.A.
solution pour application cutanée: Minoxidilum 20 mg/ml
Bailleul (Suisse) SA
D
FB
G
IP
CI
Minorga 2 %
3 x 60 ml
k.A.
solution pour application cutanée: Minoxidilum 20 mg/ml
Bailleul (Suisse) SA
D
FB
G
IP
CI
Minoxidil Leman 20 mg/ml
60 ml
k.A.
solution pour application cutanée: Minoxidilum 20 mg/ml
Leman SKL SA
D
FB
G
IP
CI
Minoxidil Leman 20 mg/ml
3 x 60 ml
k.A.
solution pour application cutanée: Minoxidilum 20 mg/ml
Leman SKL SA
D
FB
G
IP
CI
Minoxidil Leman 50 mg/ml
60 ml
k.A.
solution pour application cutanée: Minoxidilum 50 mg/ml
Leman SKL SA
D
FB
G
IP
CI
Minoxidil Leman 50 mg/ml
3 x 60 ml
k.A.
solution pour application cutanée: Minoxidilum 50 mg/ml
Leman SKL SA
D
FB
G
IP
CI
Alopexy 2%
60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Alopexy 2%
3 x 60 ml
k.A.
Solution: Minoxidilum 20 mg/ml
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Alopexy 5%
60 ml
k.A.
Lösung zur Anwendung auf der Haut: Minoxidilum
Pierre Fabre Pharma SA
D
FB
G
IP
CI
Piloxil
50 ml
k.A.
Solution: Minoxidilum 20 mg
Laboratoire Golaz SA
C
FB
G
IP
CI
Piloxil
50 ml
k.A.
Solution: Minoxidilum 20 mg
Laboratoire Golaz SA
C
FB
G
Gamolenic Acid (D11AX02) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Ph
Epogam 1000
120
41.80
77.20
10 %
Capsules: Oenotherae Seminis Oleum 1000 mg
Zeller Medical AG
D / SL
FB
G
IP
CI
Ph
Epogam 1000
240
73.48
135.70
10 %
Capsules: Oenotherae Seminis Oleum 1000 mg
Zeller Medical AG
D / SL
FB
G
Finasteride (D11AX10) 18 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Andropecia Biorga 1 mg
28
k.A.
Coated tablets: Finasteridum 1 mg
Bailleul (Suisse) SA
B
FB
G
IP
CI
Andropecia Biorga 1 mg
84
k.A.
Coated tablets: Finasteridum 1 mg
Bailleul (Suisse) SA
B
FB
G
IP
CI
Finacapil
28 Tablet(s)
k.A.
Coated tablets: Finasteridum 1 mg
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Finacapil
98 Tablet(s)
k.A.
Coated tablets: Finasteridum 1 mg
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Propecia
84
k.A.
Coated tablets: Finasteridum 1 mg
Organon GmbH
B
FB
G
IP
CI
Finasterid-Mepha Procapil
28 Tablet(s)
k.A.
Filmtablette: Finasteridum 1 mg
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Finasterid-Mepha Procapil
98 Tablet(s)
k.A.
Filmtablette: Finasteridum 1 mg
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Fynzur 2,275 mg/ml
18 ml
k.A.
solution pour pulvérisation cutanée: Finasteridum 114 µg
Bailleul (Suisse) SA
B
FB
G
IP
CI
Andropecia Biorga 1 mg
7
k.A.
Coated tablets: Finasteridum 1 mg
Bailleul (Suisse) SA
B
FB
G
IP
CI
Andropecia Biorga 1 mg
30
k.A.
Coated tablets: Finasteridum 1 mg
Bailleul (Suisse) SA
B
FB
G
IP
CI
Andropecia Biorga 1 mg
98
k.A.
Coated tablets: Finasteridum 1 mg
Bailleul (Suisse) SA
B
FB
G
Finasterid NOBEL, 1mg
28
k.A.
Coated tablets: Finasteridum 1 mg
NOBEL Pharma Schweiz AG
B
FB
G
Finasterid NOBEL, 1mg
84
k.A.
Coated tablets: Finasteridum 1 mg
NOBEL Pharma Schweiz AG
B
FB
G
Finasterid NOBEL, 1mg
98
k.A.
Coated tablets: Finasteridum 1 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Finasteride Leman 1 mg
28
k.A.
Coated tablets: Finasteridum 1 mg
Leman SKL SA
B
FB
G
IP
CI
Finasteride Leman 1 mg
84
k.A.
Coated tablets: Finasteridum 1 mg
Leman SKL SA
B
FB
G
IP
CI
Finasteride Leman 1 mg
98
k.A.
Coated tablets: Finasteridum 1 mg
Leman SKL SA
B
FB
G
IP
CI
Fynzur 2,275 mg/ml
3 x 18 ml
k.A.
solution pour pulvérisation cutanée: Finasteridum 114 µg
Bailleul (Suisse) SA
B
FB
G
Hydroquinone (D11AX11) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Pigmanorm
30 g
9.51
26.75
10 %
Cream: 3 Active Agents
Louis Widmer AG
B / SL
FB
G
Eflornithine (D11AX16) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Vaniqa
30 g
k.A.
Cream: Eflornithinum 115 mg
Almirall AG
B
FB
G
IP
CI
Vaniqa
60 g
148.65
k.A.
Cream: Eflornithinum 115 mg
Almirall AG
B / LPPV
FB
G
Diclofenac (D11AX18) 6 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Solaraze 3%
25 g
15.62
33.25
10 %
Gel: Diclofenacum Natricum 30 mg
Almirall AG
B / SL / SO
FB
G
IP
CI
Solaraze 3%
50 g
27.48
46.05
10 %
Gel: Diclofenacum Natricum 30 mg
Almirall AG
B / SL / SO
FB
G
IP
CI
Solacutan 3%
25 g
13.27
30.85
10 %
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Solacutan 3%
50 g
23.36
41.80
10 %
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Solaraze 3%
100 g
k.A.
Gel: Diclofenacum Natricum 30 mg
Almirall AG
B
FB
G
IP
CI
Solacutan 3%
100 g
k.A.
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B
FB
G
Brimonidine (D11AX21) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
PP
Mirvaso 3.3mg/g
30 g
37.44
57.15
10 %
Gel: Brimonidini Tartras 5 mg
Galderma SA
B / SL
FB
G
Ivermectin (D11AX22) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
PP
Soolantra 10 mg
30 g
16.37
34.20
10 %
Cream: Ivermectinum 10 mg
Galderma SA
B / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home